ArticleNeuropharmacology2010

MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism.

Melanie A Paquette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.